Chart of Day: Johnson & Johnson (JNJ) – 4/25

After diving to $143.13, Johnson & Johnson (SYM: JNJ) are starting to pivot from triple-bottom support dating back to November. Analysts at HSBC like it here, too, upgrading JNJ shares to a buy rating with a price target of $170.

jnj
“The shares have retreated to three-year lows despite fundamentals that are unchanged and headwinds that are well known,” says the analyst, who sees “asymmetric risk and attractive upside” as well as “diversity that limits material operational downside for J&J,” added HSBC, as quoted by TheFly.com.

Plus, the company just won one of its talc lawsuits. A Florida jury found that JNJ’s baby powder talc did not cause the ovarian cancer of a Florida woman.

deal of the month

best growth stocks

Alliance

Bundle package – lifetime subscriptions for all products

Categories

Recent posts

Tags

Connect with Us

Get FREE Daily Stock Tips

Join and receive market insider stock picks, trade alerts and unique investing insights
This field is for validation purposes and should be left unchanged.
By clicking the "Subscribe" button you are accepting our Terms of Use and Privacy Policy.

Join Waitlist

We’re sorry, but due to the popularity of our services, we have reached our max number of subscribers and are not currently accepting more. If spots become available, we will be sure to contact you. Please join the waitlist below.
Thank You!

"*" indicates required fields

Name*
This field is for validation purposes and should be left unchanged.